These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 125386)

  • 1. Catecholamines and neurologic diseases (second of two parts).
    Moskowitz MA; Wurtman RJ
    N Engl J Med; 1975 Aug; 293(7):332-8. PubMed ID: 125386
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain catecholamines and neurological disease.
    Wurtman RJ; Moskowitz MA
    Trans Am Neurol Assoc; 1974; 99():149-59. PubMed ID: 4282535
    [No Abstract]   [Full Text] [Related]  

  • 3. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
    Marsden CD
    Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927
    [No Abstract]   [Full Text] [Related]  

  • 4. Involuntary movement disorders.
    Still CN
    Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amine precursors in neurologic disorders and the psychoses.
    Klawans H
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():259-76. PubMed ID: 130667
    [No Abstract]   [Full Text] [Related]  

  • 6. Involuntary movements other than Parkinsonism: biochemical aspects.
    Curzon G
    Proc R Soc Med; 1973 Sep; 66(9):873-6. PubMed ID: 4281484
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neurologic indications for bromocriptine (in addition to Parkinson's disease)].
    Destee A
    LARC Med; 1984 Feb; 4(2):107-11. PubMed ID: 6232436
    [No Abstract]   [Full Text] [Related]  

  • 8. Network biomarkers for the diagnosis and treatment of movement disorders.
    Poston KL; Eidelberg D
    Neurobiol Dis; 2009 Aug; 35(2):141-7. PubMed ID: 19013242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral infections in the central nervous system and 5-hydroxytryptamine metabolism.
    Roos BE; Lycke E
    Adv Biochem Psychopharmacol; 1974; 11(0):115-7. PubMed ID: 4845694
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of catecholamines in the pathogenesis of extrapyramidal hyperkinesis].
    Barkhatova VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):212-9. PubMed ID: 2939669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorders of the autonomic nervous system. Chapter 6. Arterial hypotension.
    Johnson RH; Spaulding JM
    Contemp Neurol Ser; 1974; (11):79-113. PubMed ID: 4615877
    [No Abstract]   [Full Text] [Related]  

  • 12. Catecholamines and neurologic diseases (first of two parts).
    Moskowitz MA; Wurtman RJ
    N Engl J Med; 1975 Aug; 293(6):274-80. PubMed ID: 166316
    [No Abstract]   [Full Text] [Related]  

  • 13. The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases.
    Papeschi R; Molina-Negro P; Sourkes TL; Erba G
    Neurology; 1972 Nov; 22(11):1151-9. PubMed ID: 4263829
    [No Abstract]   [Full Text] [Related]  

  • 14. [The pathogenetic significance of metabolic disorders in hereditary extrapyramial diseases].
    Tkachev RA; Markova ED; Gotovtseva EV; Bauman LK; Barkhatova VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):512-20. PubMed ID: 4250562
    [No Abstract]   [Full Text] [Related]  

  • 15. Serotonergic mechanisms and extrapyramidal function in man.
    Chase TN
    Adv Neurol; 1974; 5():31-9. PubMed ID: 4280243
    [No Abstract]   [Full Text] [Related]  

  • 16. Catecholamines and neurologic diseases.
    Wurtman RJ
    N Engl J Med; 1970 Jan; 282(1):45-6. PubMed ID: 5409471
    [No Abstract]   [Full Text] [Related]  

  • 17. Approaches to the study of cerebral dopamine metabolism in certain extrapyramidal diseases.
    Barkhatova VP; Kandel' EI; Demina EG
    Neurosci Behav Physiol; 1985; 15(2):132-9. PubMed ID: 3160969
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of catecholamine metabolism in two hereditary forms of dystonia.
    Wotten GF; Eldridge R; Gordon EK; Axelrod J
    Trans Am Neurol Assoc; 1973; 98():245-7. PubMed ID: 4784942
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutics of disordered movement.
    Sears ES
    Am Fam Physician; 1977 Sep; 16(3):145-54. PubMed ID: 143204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary Parkinsonism-dystonia with sustained control by L-DOPA and anticholinergic medication.
    Allen N; Knopp W
    Adv Neurol; 1976; 14():201-13. PubMed ID: 942621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.